Citation
Zullo, Marzio Angelo, et al. "One-year Follow-up of Tension-free Vaginal Tape (TVT) and Trans-obturator Suburethral Tape From Inside to Outside (TVT-O) for Surgical Treatment of Female Stress Urinary Incontinence: a Prospective Randomised Trial." European Urology, vol. 51, no. 5, 2007, pp. 1376-82; discussion 1383-4.
Zullo MA, Plotti F, Calcagno M, et al. One-year follow-up of tension-free vaginal tape (TVT) and trans-obturator suburethral tape from inside to outside (TVT-O) for surgical treatment of female stress urinary incontinence: a prospective randomised trial. Eur Urol. 2007;51(5):1376-82; discussion 1383-4.
Zullo, M. A., Plotti, F., Calcagno, M., Marullo, E., Palaia, I., Bellati, F., Basile, S., Muzii, L., Angioli, R., & Panici, P. B. (2007). One-year follow-up of tension-free vaginal tape (TVT) and trans-obturator suburethral tape from inside to outside (TVT-O) for surgical treatment of female stress urinary incontinence: a prospective randomised trial. European Urology, 51(5), 1376-82; discussion 1383-4.
Zullo MA, et al. One-year Follow-up of Tension-free Vaginal Tape (TVT) and Trans-obturator Suburethral Tape From Inside to Outside (TVT-O) for Surgical Treatment of Female Stress Urinary Incontinence: a Prospective Randomised Trial. Eur Urol. 2007;51(5):1376-82; discussion 1383-4. PubMed PMID: 17110021.
TY - JOUR
T1 - One-year follow-up of tension-free vaginal tape (TVT) and trans-obturator suburethral tape from inside to outside (TVT-O) for surgical treatment of female stress urinary incontinence: a prospective randomised trial.
AU - Zullo,Marzio Angelo,
AU - Plotti,Francesco,
AU - Calcagno,Marco,
AU - Marullo,Elettra,
AU - Palaia,Innocenza,
AU - Bellati,Filippo,
AU - Basile,Stefano,
AU - Muzii,Ludovico,
AU - Angioli,Roberto,
AU - Panici,Pierluigi Benedetti,
Y1 - 2006/11/07/
PY - 2006/07/25/received
PY - 2006/10/26/accepted
PY - 2006/11/18/pubmed
PY - 2007/7/4/medline
PY - 2006/11/18/entrez
SP - 1376-82; discussion 1383-4
JF - European urology
JO - Eur Urol
VL - 51
IS - 5
N2 - OBJECTIVES: To compare tension-free vaginal tape (TVT) and trans-obturator suburethral tape from inside to outside (TVT-O) for surgical treatment of stress urinary incontinence (SUI) for complications (primary end point) and success rate (secondary end point). METHODS: Seventy-two consecutive patients, with a mean age of 53.2 yr (range: 38-69 yr) and affected by SUI, were included in this randomised controlled trial. After preoperative assessment, patients were randomly allocated to the TVT or TVT-O procedure. Operative time, perioperative complications, and hospital stay were prospectively recorded. Cure of SUI was defined as no leakage of urine during the stress test at urodynamic testing at the 12-mo evaluation. The Wilcoxon signed rank sum test, Mann-Whitney U test, McNemar test, and Fisher exact test were used to verify statistical significance, set at p<0.05. RESULTS: All patients were evaluable at the 12-mo follow-up. The characteristics of patients were well balanced between groups after randomisation. The mean operative time was significantly shorter in the TVT-O group. Perioperative complications were significantly more common after the retropubic approach (5% and 27% in TVT-O and TVT groups, respectively, p<0.04). The groups did not differ significantly in intraoperative blood loss, hospital stays, and time to return to normal activities. Sixty-five patients (90%) were successfully treated for SUI 12 mo after the operation (89% and 91% for TVT-O and TVT groups, respectively). CONCLUSIONS: Both techniques appear to be equally effective in the surgical treatment of SUI. However, TVT-O had a shorter operative time and lower overall perioperative complication rate.
SN - 0302-2838
UR - https://www.unboundmedicine.com/medline/citation/17110021/One_year_follow_up_of_tension_free_vaginal_tape__TVT__and_trans_obturator_suburethral_tape_from_inside_to_outside__TVT_O__for_surgical_treatment_of_female_stress_urinary_incontinence:_a_prospective_randomised_trial_
L2 - https://linkinghub.elsevier.com/retrieve/pii/S0302-2838(06)01360-1
DB - PRIME
DP - Unbound Medicine
ER -